Navina, an AI-powered clinical intelligence platform, has successfully secured $55 million in a Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors Vertex Ventures Israel, Grove Ventures, and ALIVE. This latest investment brings Navina's total funding to $100 million.
Founded in 2018, Navina integrates artificial intelligence with electronic health record (EHR) systems to provide clinical insights, flag potential diagnoses, identify risk factors, and detect medication conflicts. The platform is currently utilized by over 1,300 clinics in the United States, aiming to enhance care quality and patient outcomes by efficiently managing and analyzing patient data.
The newly acquired funds will be used to accelerate Navina's expansion across the U.S. healthcare market, enhance its proprietary AI technology, and further drive improvements in patient outcomes by bringing proactive clinical intelligence to every outpatient interaction.
Navina plans to use the new funding to enhance its offerings, including developing ambient scribing capabilities for full documentation support. While not yet profitable, CEO Ronen Lavi aims for profitability within the next two to three years.
Navina's competitive edge lies in its alignment with clinics' financial needs and a strong provider experience, setting it apart in a competitive market of AI in healthcare data analysis.
Source: TechinAsia
#healthcarestartupindia #dseidehealthcarenetwork
Founded in 2018, Navina integrates artificial intelligence with electronic health record (EHR) systems to provide clinical insights, flag potential diagnoses, identify risk factors, and detect medication conflicts. The platform is currently utilized by over 1,300 clinics in the United States, aiming to enhance care quality and patient outcomes by efficiently managing and analyzing patient data.
The newly acquired funds will be used to accelerate Navina's expansion across the U.S. healthcare market, enhance its proprietary AI technology, and further drive improvements in patient outcomes by bringing proactive clinical intelligence to every outpatient interaction.
Navina plans to use the new funding to enhance its offerings, including developing ambient scribing capabilities for full documentation support. While not yet profitable, CEO Ronen Lavi aims for profitability within the next two to three years.
Navina's competitive edge lies in its alignment with clinics' financial needs and a strong provider experience, setting it apart in a competitive market of AI in healthcare data analysis.
Source: TechinAsia
#healthcarestartupindia #dseidehealthcarenetwork
Navina, an AI-powered clinical intelligence platform, has successfully secured $55 million in a Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors Vertex Ventures Israel, Grove Ventures, and ALIVE. This latest investment brings Navina's total funding to $100 million.
Founded in 2018, Navina integrates artificial intelligence with electronic health record (EHR) systems to provide clinical insights, flag potential diagnoses, identify risk factors, and detect medication conflicts. The platform is currently utilized by over 1,300 clinics in the United States, aiming to enhance care quality and patient outcomes by efficiently managing and analyzing patient data.
The newly acquired funds will be used to accelerate Navina's expansion across the U.S. healthcare market, enhance its proprietary AI technology, and further drive improvements in patient outcomes by bringing proactive clinical intelligence to every outpatient interaction.
Navina plans to use the new funding to enhance its offerings, including developing ambient scribing capabilities for full documentation support. While not yet profitable, CEO Ronen Lavi aims for profitability within the next two to three years.
Navina's competitive edge lies in its alignment with clinics' financial needs and a strong provider experience, setting it apart in a competitive market of AI in healthcare data analysis.
Source: TechinAsia
#healthcarestartupindia #dseidehealthcarenetwork
